HD-tACS for Alcohol Use Disorder
Key facts
- Who runs it
- Shanghai Mental Health Center
- Where
- China1 site in 1 countryChoose a country to see its sites
- Trial code
- Status
- Not yet recruiting
- People taking part
- 140 people, planned
- Started
- 1 Sept 2026
- Expected to end
- 31 Dec 2026
- Type of study
- Interventional, 2 groupsOne group gets a sham (pretend) treatment, for comparison.
- Treatments tested
- HD-tACS
- Sham HD-tACS
- Record updated
- 8 September 2026
Who can take part
- Age
- 18 years to 55 years
- Sex
- Women and men
- Healthy volunteers
- Cannot take part
The registry criteria, word for word
Show all 14 criteriaShow less
Who can take part
- Age range: 18-55 years old, gender not restricted
- Meets the DSM-5 diagnostic criteria for alcohol use disorder (moderate to severe)
- AUDIT score ≥ 16
- Baseline score after alcohol cue-induced stimulation is ≥ 3
- Completed detoxification treatment before enrollment (moderate to severe), with detoxification duration of ≥ 7 days and ≤ 90 days
- Has a primary school education or above, and can understand and complete the research assessment
- Voluntarily participated in the study and signed the informed consent form
Who cannot take part
- Has received electroconvulsive therapy (ECT), transcranial electrical/magnetic/ultrasound stimulation within the past 6 months
- Currently, there are other substance use disorders (except nicotine)
- Currently, there are schizophrenia, bipolar disorder or other severe psychotic disorders
- Has a history of epilepsy or family history of epilepsy
- Has a history of brain trauma, brain surgery or intracranial metal implants
- Pregnant or lactating women
- Other situations that the researchers consider unsuitable for participation in this study
Check if you might fit
Answer for yourself. This is not a decision: only the study team can say whether you can take part.
- Are you between 18 and 55 years old?
This trial has no sites in United States.
It has sites in one country. Choose a country to see its sites.
About the trial
What the trial wants to find out
This study aims to systematically explore the effectiveness of accelerated HD-tACS in treating AUD, particularly its efficacy in reducing alcohol craving and preventing relapse in AUD patients.
The 2 groups in the trial
- HD-tACS groupTreatment being tested
Using the transcranial electrical stimulation device, with the ring-shaped focusing technology, the current is locked in the target area through a 4\*1 electrode configuration, causing the peak to appear below the central electrode.
Treatment: HD-tACS
- Sham HD-tACS groupSham treatment, for comparison
Using the transcranial electrical stimulation device, with the ring-shaped focusing technology, the current is locked in the target area through a 4\*1 electrode configuration, causing the peak to appear below the central electrode.
Treatment: Sham HD-tACS
Questions to ask the study team
- How often do I need to come in, and for how long each time?
- Are travel costs paid?
- Can I keep my own doctor?
- What happens if I want to stop?
Contact the study team: see the registry record → Contacts and Locations
Print a page for my doctorSaves a reminder to your own calendar to look at this page again. Frontlight sends no messages and does not know you set it.
Data and sources
- Registry record
- Listed on ClinicalTrials.gov.How to verify a trial in the registry
- Official title
- Accelerated High-Definition Transcranial Alternating Current Stimulation (HD-tACS) for Alcohol Use Disorder: A Randomized Controlled Trial
- Fit questions
- Built from NCT07808190, who can take part
- Record updated
- 8 September 2026